Arai H, Yuda T, Goodgold H M, Martin T W, Swartz M T, Pennington D G
Department of Surgery, St. Louis University Medical Center 63110-0250.
J Heart Lung Transplant. 1992 Jul-Aug;11(4 Pt 1):763-72.
Lymphocytic accumulation in different areas of the myocardium during different phases of acute rejection were studied in rat heterotopic cardiac and cardiopulmonary allograft and isograft transplantation models. Indium 111-labeled syngeneic lymphocytes were injected 1 to 7 days after transplantation, and accumulation of the labeled cells in the graft was determined 24 hours later. The cardiac graft was divided into three segments: right ventricular (RV) free wall, epicardial portion of the left ventricle (LV) plus RV septum, and endocardial portion of the LV. In the subsequent heart-lung transplantation group, the LV epicardial portion plus RV septum segment was subdivided into LV epicardial portion and RV septum. Lymphocytic accumulation in each segment was compared between three groups according to the day the animal was killed after transplantation: days 2, 3 (group 1), days 4, 5 (group 2), and days 6, 7, 8 (group 3). Lymphocytic accumulation caused by rejection in group 1 and group 2 of both the cardiac and cardiopulmonary allografts showed significantly different intramyocardial distribution (p less than 0.01). Lymphocytic accumulation was consistently highest in RV free wall and lowest in LV endocardial portion. In group 3 specimens, lymphocytic accumulation was symmetrical in both the cardiac and cardiopulmonary allografts. In the cardiac allograft, the lymphocytic accumulation increased sharply on day 4 then declined to a nadir. This transient increase was not so pronounced in the cardiopulmonary allografts. The significantly decreased intramyocardial lymphocytic accumulation in group 2 of the cardiopulmonary allografts when compared with the cardiac allografts (p less than 0.01) is compatible with the clinical observation of a lower incidence of acute heart rejection in heart-lung transplant recipients. These data show an asymmetric accumulation of lymphocytes during acute heart rejection, which is due to increased lymphocytic affinity for the RV free wall.
在大鼠异位心脏、心肺同种异体移植和同基因移植模型中,研究了急性排斥反应不同阶段心肌不同区域的淋巴细胞积聚情况。移植后1至7天注射铟111标记的同基因淋巴细胞,24小时后测定标记细胞在移植物中的积聚情况。心脏移植物分为三个节段:右心室游离壁、左心室心外膜部分加右心室间隔以及左心室心内膜部分。在随后的心肺移植组中,左心室心外膜部分加右心室间隔节段再细分为左心室心外膜部分和右心室间隔。根据移植后处死动物的天数,比较三组中每个节段的淋巴细胞积聚情况:第2、3天(第1组),第4、5天(第2组),以及第6、7、8天(第3组)。心脏和心肺同种异体移植的第1组和第2组中,由排斥反应引起的淋巴细胞积聚显示出心肌内分布有显著差异(p小于0.01)。淋巴细胞积聚在右心室游离壁始终最高,在左心室心内膜部分最低。在第3组标本中,心脏和心肺同种异体移植中的淋巴细胞积聚都是对称的。在心脏同种异体移植中,淋巴细胞积聚在第4天急剧增加,然后降至最低点。这种短暂增加在心肺同种异体移植中不那么明显。与心脏同种异体移植相比,心肺同种异体移植第2组中心肌内淋巴细胞积聚显著减少(p小于0.01),这与心肺移植受者急性心脏排斥发生率较低的临床观察结果相符。这些数据表明,急性心脏排斥期间淋巴细胞积聚不对称,这是由于淋巴细胞对右心室游离壁的亲和力增加所致。